SNTI
SNTI
NASDAQ · Biotechnology

Senti Biosciences Inc

$0.31
-0.02 (-5.86%)
As of Sep 28, 10:36 PM ET ·
Financial Highlights (FY 2026)
Revenue
30.3K
Net Income
-82,915,556
Gross Margin
—
Profit Margin
-279,263.6%
Rev Growth
-82.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 52.7% 52.7%
Operating Margin -312,631.8% -281,369.4% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 30.3K 175.9K 15.18M 16.45M
Gross Profit — — 8.01M 8.68M
Operating Income -94,861,873 -494,931,511 1.19M 1.25M
Net Income -82,915,556 -432,602,900 1.21M 962.0K
Gross Margin — — 52.7% 52.7%
Operating Margin -312,631.8% -281,369.4% 7.9% 7.6%
Profit Margin -279,263.6% -265,300.5% 8.0% 5.9%
Rev Growth -82.8% -82.8% +1.7% +13.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 3.21M 3.14M
Total Equity — — 9.87M 10.49M
D/E Ratio — — 0.33 0.30
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -89,132,857 -490,876,603 1.98M 2.22M
Free Cash Flow — — 1.07M 1.04M